Corporate Governance

Burjeel Holdings is committed to the highest levels of governance. In 2022 we appointed a Board of Directors with significant international industry and governance experience to help guide us through our next phase of expansion. Our Board of Directors is supported by an Audit Committee, a Nomination and Remuneration Committee and a Clinical and Medical Advisory Committee. The Company is led by a high quality senior management team with a wealth of industry experience.

The Clinical and Medical Advisory Committee provides support and advice to the Board in relation to programs for clinical pathways, the standardisation of care, the identification of best-practice standards, quality and patient safety related KPIs and quality improvement programs. It supports and advises on training, mentoring and development, and provides a connection to, and ongoing exchange of information and ideas with, practitioners in the field and other external contacts.

Across all our brands and businesses, we have implemented effective and transparent governance frameworks, in line with best in class standards and regulatory requirements.

Corporate Governance and Compliance

• Document 1
• Document 2
• Document 3
• Document 4